Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA   US04033A1007

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/26/2015 03/27/2015 03/30/2015 03/31/2015 04/01/2015 Date
8.17(c) 8.39(c) 8.56(c) 8.24(c) 8.1(c) Last
5 860 576 4 653 544 6 523 040 5 176 688 6 841 663 Volume
+0.99% +2.69% +2.03% -3.74% -1.70% Change
More quotes
Financials ($)
Sales 2015 153 M
EBIT 2015 -183 M
Net income 2015 -187 M
Finance 2015 80,5 M
Yield 2015 -
Sales 2016 213 M
EBIT 2016 -136 M
Net income 2016 -125 M
Finance 2016 76,8 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 9,41x
EV / Sales 2016 6,78x
Capitalization 1 519 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.The company has four products: Ridaforolimus, Ponatinib, AP1903 and AP26113.Its approach to structure-based drug... 
Sector
Pharmaceuticals
Calendar
04/19 | 01:00pmPresentation
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
03/25 ARIAD PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-..
03/25 ARIAD PHARMACEUTICALS : Announces Dismissal of Shareholder Class Action Lawsuit ..
03/24 ARIAD PHARMACEUTICALS : and Medison Pharma Announce Approval of Iclusig (Ponatin..
03/22 ARIAD PHARMACEUTICALS : Reports on Dismissal of Shareholder Derivative Lawsuit i..
03/19 ARIAD PHARMACEUTICALS : Announces Presentations of Preclinical Data at American ..
03/18 ARIAD PHARMACEUTICALS : Announces Dismissal of Shareholder Derivative Lawsuit in..
03/13 ARIAD PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-..
03/13 ARIAD PHARMACEUTICALS : Updates on Dismissal of Shareholder Derivative Lawsuit i..
More news
Sector news : Biopharmaceuticals
02:09a Pfizer to shutter vaccines sales business in China
04/01 VALEANT PHARMACEUTICALS INTL : BRIEF: Valeant completes Salix acquisition
04/01 VALEANT PHARMACEUTICALS INTL : Salix Provides Notice of Fundamental Changes, Mak..
More sector news : Biopharmaceuticals
News from SeekingAlpha
02/27 SEEKING ALPHA'S BIOTECH WEEKLY : Achillion Overdone, Sanofi's Toujeo A Go, And M..
02/23 What Sarissa Capital's Proxy Fight Means For Ariad Investors
02/20 SEEKING ALPHA'S BIOTECH WEEKLY : Sanofi's New Chief, Sarissa Shakes Ariad, And M..
02/20 Ariad's largest shareholder starts proxy fight to oust CEO
02/19 ARIAD Pharmaceuticals (ARIA) Harvey J. Berger on Q4 2014 Results - Earnings C..


Comments 
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF